Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOKYO Pharma Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
OKYO Pharma Limited Earnings Date And Information
OKYO Pharma Limited last posted its earnings results on Friday, July 18th, 2025. The company reported $-0.06639 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0.01639. The company had revenue of 0 for the quarter and had revenue of 0 for the year. OKYO Pharma Limited has generated $0 earnings per share over the last year ($-0.12 diluted earnings per share) and currently has a price-to-earnings ratio of -16.03. OKYO Pharma Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 3rd, 2025 based on prior year's report dates.
OKYO Pharma Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2025 | Q4 2025 | N/A | -$0.04 | N/A | $0 | $0 |
| 09/30/2024 | Q2 2025 | N/A | -$0.08 | N/A | N/A | $0 |
| 03/30/2024 | Q4 2024 | N/A | -$0.24 | N/A | N/A | $0 |
| 09/30/2023 | Q2 2024 | N/A | -$0.00 | N/A | N/A | $0 |
| 03/30/2023 | Q4 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 09/30/2022 | Q2 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 03/31/2022 | Q4 2022 | N/A | -$0.36 | N/A | N/A | $0 |
| 09/30/2021 | Q2 2022 | N/A | -$0.00 | N/A | N/A | $0 |
| 03/31/2021 | Q4 2021 | N/A | -$0.27 | N/A | N/A | $0 |
| 09/30/2020 | Q2 2021 | N/A | -$0.11 | N/A | N/A | $0 |
| 03/31/2020 | Q4 2020 | N/A | -$0.05 | N/A | N/A | $0 |
| 09/30/2019 | Q2 2020 | N/A | -$0.13 | N/A | N/A | $0 |
| 03/31/2019 | Q4 2019 | N/A | -$0.00 | N/A | N/A | $0 |
| 09/30/2018 | Q2 2019 | N/A | -$0.00 | N/A | N/A | $0 |
| 03/31/2018 | Q4 2018 | N/A | -$0.00 | N/A | N/A | $0 |
| 09/30/2017 | Q2 2018 | N/A | -$0.00 | N/A | N/A | $0 |
| 03/31/2017 | Q4 2017 | N/A | -$0.00 | N/A | N/A | $0 |
| 09/30/2016 | Q2 2017 | N/A | -$0.00 | N/A | N/A | $0 |
| 03/31/2016 | Q4 2016 | N/A | -$0.00 | N/A | N/A | $0 |
| 09/30/2015 | Q2 2016 | N/A | -$0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
OKYO Pharma Limited Earnings: FAQ's
OKYO Pharma Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 3rd, 2025 based offlast year's report dates.
The conference call for OKYO Pharma Limited's latest earnings report can be listened to online.
The conference call transcript for OKYO Pharma Limited's latest earnings report can be read online.
OKYO Pharma Limited (:OKYO) has a recorded net income of $-4,706,292.OKYO Pharma Limited has generated $-0.12 earnings per share over the last four quarters.
OKYO Pharma Limited (:OKYO) has a price-to-earnings ratio of -16.03 and price/earnings-to-growth ratio is -0.26.